KalVista Pharmaceuticals, Inc.
DE ˙ DB ˙ US4834971032
23,01 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:4XC1 / KalVista Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership97,726 shares
Latest Disclosed Value $ 1,967,224
Citadel Advisors Llc ownership in 4XC1 / KalVista Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 97,726 shares of KalVista Pharmaceuticals, Inc. (DE:4XC1) valued at $1,514,753 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 37,761 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of 158.80% during the quarter. The current value of the position is $2,248,675 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (4XC1) in the form of stock options. The firm currently holds call options representing 71,700 of underlying shares valued at $1,443,321 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:4XC1 / KalVista Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 97,726 59,965 158.80 1,967 222.99 0.0003
2026-02-17 2025-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 37,761 37,761 610 0.0001
2025-11-14 2025-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -15,841 -100.00 0 -100.00
2025-08-14 2025-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 15,841 15,841 179 0.0000
2025-05-15 2025-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -136,493 -100.00 0 -100.00
2025-02-14 2024-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 136,493 9,244 7.26 1,156 -21.52 0.0002
2024-11-14 2024-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 127,249 108,427 576.07 1,474 566.52 0.0003
2024-08-14 2024-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 18,822 -68,262 -78.39 222 -78.59 0.0000
2024-05-15 2024-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 87,084 -696,614 -88.89 1,033 -89.25 0.0002
2024-02-14 2023-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 783,698 -144,804 -15.60 9,600 7.37 0.0019
2023-11-14 2023-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 928,502 81,896 9.67 8,941 17.35 0.0019
2023-08-14 2023-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 846,606 718,211 559.38 7,619 655.10 0.0016
2023-05-15 2023-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 128,395 26,868 26.46 1,009 47.08 0.0002
2023-02-14 2022-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 101,527 -37,995 -27.23 686 -66.11 0.0002
2022-11-14 2022-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 139,522 -33,759 -19.48 2,024 18.71 0.0005
2022-08-15 2022-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 173,281 110,311 175.18 1,705 83.73 0.0004
2022-05-16 2022-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 62,970 45,564 261.77 928 303.48 0.0002
2022-02-14 2021-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 17,406 -23,256 -57.19 230 -67.61 0.0000
2021-11-15 2021-09-30 13F KALVISTA PHARMACEUTICALS Cmn 483497103 40,662 -35,186 -46.39 710 -60.95 0.0001
2021-08-16 2021-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 75,848 30,437 67.03 1,818 55.78 0.0004
2021-05-21 2021-03-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 45,411 45,411 1,167 0.0003
2021-05-17 2021-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 45,411 45,411 1,167 0.0003
2020-08-14 2020-06-30 13F KALVISTA PHARMACEUTICALS Cmn 483497103 0 -93,503 -100.00 0 -100.00
2020-05-15 2020-03-31 13F KALVISTA PHARMACEUTICALS Cmn 483497103 93,503 93,503 715 0.0003
2020-02-14 2019-12-31 13F KALVISTA PHARMACEUTICALS Cmn 483497103 0 -10,194 -100.00 0 -100.00
2019-11-14 2019-09-30 13F KALVISTA PHARMACEUTICALS Cmn 483497103 10,194 -10,878 -51.62 118 -74.73 0.0001
2019-08-14 2019-06-30 13F KALVISTA PHARMACEUTICALS Cmn 483497103 21,072 21,072 467 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KALVISTA PHARMACEUTICALS COM Call 71,700 156.07 1,443 219.25 n/a n/a n/a
2026-02-17 2025-12-31 13F KALVISTA PHARMACEUTICALS COM Call 28,000 452 n/a n/a n/a
2025-08-14 2025-06-30 13F KALVISTA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F KALVISTA PHARMACEUTICALS COM Call 42,400 214.07 489 328.95 n/a n/a n/a
2025-02-14 2024-12-31 13F KALVISTA PHARMACEUTICALS COM Call 13,500 610.53 114 418.18 n/a n/a n/a
2024-11-14 2024-09-30 13F KALVISTA PHARMACEUTICALS COM Call 1,900 -79.57 22 -79.82 n/a n/a n/a
2024-08-14 2024-06-30 13F KALVISTA PHARMACEUTICALS COM Call 9,300 -40.38 110 -41.08 n/a n/a n/a
2024-05-15 2024-03-31 13F KALVISTA PHARMACEUTICALS COM Call 15,600 -68.86 185 -69.82 n/a n/a n/a
2024-02-14 2023-12-31 13F KALVISTA PHARMACEUTICALS COM Call 50,100 245.52 614 341.01 n/a n/a n/a
2023-11-14 2023-09-30 13F KALVISTA PHARMACEUTICALS COM Call 14,500 2,316.67 140 2,680.00 n/a n/a n/a
2023-08-14 2023-06-30 13F KALVISTA PHARMACEUTICALS COM Call 600 -14.29 5 0.00 n/a n/a n/a
2023-05-15 2023-03-31 13F KALVISTA PHARMACEUTICALS COM Call 700 -84.78 6 -83.87 n/a n/a n/a
2023-02-14 2022-12-31 13F KALVISTA PHARMACEUTICALS COM Call 4,600 -97.78 31 -98.97 n/a n/a n/a
2022-11-14 2022-09-30 13F KALVISTA PHARMACEUTICALS COM Call 207,300 -44.82 3,008 -18.64 n/a n/a n/a
2022-08-15 2022-06-30 13F KALVISTA PHARMACEUTICALS COM Call 375,700 425.45 3,697 250.76 n/a n/a n/a
2022-05-16 2022-03-31 13F KALVISTA PHARMACEUTICALS COM Call 71,500 1,054 n/a n/a n/a
2022-03-11 2021-09-30 13F/A KALVISTA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F KALVISTA PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F KALVISTA PHARMACEUTICALS COM Call 24,100 -42.89 577 -46.77 n/a n/a n/a
2021-05-21 2021-03-31 13F/A KALVISTA PHARMACEUTICALS COM Call 42,200 -36.92 1,084 -14.65 n/a n/a n/a
2021-05-17 2021-03-31 13F KALVISTA PHARMACEUTICALS COM Call 42,200 1,084 n/a n/a n/a
2021-02-16 2020-12-31 13F KALVISTA PHARMACEUTICALS COM Call 66,900 1,270 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-14 2025-06-30 13F KALVISTA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F KALVISTA PHARMACEUTICALS COM Put 6,000 -83.61 69 -77.74 n/a n/a n/a
2025-02-14 2024-12-31 13F KALVISTA PHARMACEUTICALS COM Put 36,600 -62.65 310 -72.66 n/a n/a n/a
2024-11-14 2024-09-30 13F KALVISTA PHARMACEUTICALS COM Put 98,000 910.31 1,135 894.74 n/a n/a n/a
2024-08-14 2024-06-30 13F KALVISTA PHARMACEUTICALS COM Put 9,700 -67.77 114 -67.98 n/a n/a n/a
2024-05-15 2024-03-31 13F KALVISTA PHARMACEUTICALS COM Put 30,100 -3.53 357 -6.81 n/a n/a n/a
2024-02-14 2023-12-31 13F KALVISTA PHARMACEUTICALS COM Put 31,200 1,980.00 382 2,628.57 n/a n/a n/a
2023-11-14 2023-09-30 13F KALVISTA PHARMACEUTICALS COM Put 1,500 14 n/a n/a n/a
2023-05-15 2023-03-31 13F KALVISTA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F KALVISTA PHARMACEUTICALS COM Put 13,300 90 n/a n/a n/a
2022-02-14 2021-12-31 13F KALVISTA PHARMACEUTICALS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F KALVISTA PHARMACEUTICALS Cmn Put 27,900 -37.72 487 -54.61 n/a n/a n/a
2021-08-16 2021-06-30 13F KALVISTA PHARMACEUTICALS COM Put 44,800 -69.23 1,073 -71.31 n/a n/a n/a
2021-05-21 2021-03-31 13F/A KALVISTA PHARMACEUTICALS COM Put 145,600 -19.74 3,740 8.56 n/a n/a n/a
2021-05-17 2021-03-31 13F KALVISTA PHARMACEUTICALS COM Put 145,600 3,740 n/a n/a n/a
2021-02-16 2020-12-31 13F KALVISTA PHARMACEUTICALS COM Put 181,400 3,445 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.